Trials / Completed
CompletedNCT06654856
The Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis
A Prospective, Multicenter, Single Group, Open-label and Observational Study to Evaluate the Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 107 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis
Conditions
Timeline
- Start date
- 2024-08-16
- Primary completion
- 2026-02-23
- Completion
- 2026-02-23
- First posted
- 2024-10-23
- Last updated
- 2026-02-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06654856. Inclusion in this directory is not an endorsement.